Drug Profile
Research programme: neuropathic pain therapy - D-Pharm
Alternative Names: DP-236Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator D-Pharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 27 Sep 2006 Discontinued - Preclinical for Neuropathic pain in Israel (unspecified route)
- 03 Jun 2005 Preclinical trials in Neuropathic pain in Israel (unspecified route)